MAPK8 and pancreatic neoplasm: Notably, the exactly identical treatment protocol that so effectively eliminated CSCs/CSLCs within the primary tumors had virtually no inhibitory effect on the growth of the primary tumors during the 10-day treatment period, implying that JNK activity is “not immediately required” for pancreatic cancer cells to maintain proliferation and survival.